Glenview Capital Management, LLC Pacific Biosciences Of California, Inc. Transaction History

Glenview Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.61 - $9.87 $11.4 Million - $31.1 Million	-3,153,150 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.65 - $4.03 $199,664 - $303,640	-75,345 Reduced 2.33%	3,153,150 $10.9 Million
Q1 2020 May 15, 2020	SELL	$2.36 - $5.26 $1.37 Million - $3.06 Million	-581,154 Reduced 15.25%	3,228,495 $9.88 Million
Q4 2019 Feb 14, 2020	BUY	$4.6 - $5.57 $17.5 Million - $21.2 Million	3,809,649 New	3,809,649 $19.6 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $443M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Glenview Capital Management, LLC with notifications on news.